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1. Introduction 
The means whereby the beta-cell of the islets of 
Langerhans recognises ignals for insulin biosynthesis 
and secretion and subsequently transduces such 
signals to activate the biosynthetic and secretory 
mechanisms are unknown. Two models have been 
proposed [I] to describe the process of signal recog- 
nition. One, the receptor-site model, envisages that 
the interaction of the signal with a membrane receptor, 
results in a change in the beta-cell initiating insulin 
release. The second model, the substrate-site model, 
proposes that the signal enters the beta-cell where it 
is metabolised and it is the formation of some metab- 
olite or cofactor which causes initiation of the 
secretory response. These models have been extended 
[2] with the development of a dual-site model to 
encompass the phenomenon of potentiation. There 
is-now an increasing body of evidence to support the 
substrate-site model. Such evidence includes close 
correlations between the rates of islet glucose metab- 
olism and the ability of glucose to cause insulin release 
[2,3] , the effects of mannoheptulose to inhibit both 
glucose phosphorylation and glucose-stimulated 
insulin release but not glyceraldehyde metabolism or 
glyceraldehyde-stimulated insulin release [2] and the 
observation that the anomeric specificity for glucose 
metabolism by the islet is the same as that for insulin 
release [4] . 
The present study is concerned with the metabolism 
and insulin-releasing activity of N-acetylglucosamine 
in isolated rat islets. The ability of N-acetylglucos- 
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amine to potentiate insulin release both in isolated rat 
and mouse islets [2,3] and in the rat in vivo [5] is 
well documented together with its ability to stimulate 
insulin biosynthesis [6] . We now find that correlations 
between the metabolism of N-acetylglucosamine and 
its ability to modulate insulin release and biosynthesis 
include the dependence on N-acetylglucosamine con- 
centration and the effects of caffeine and phloretin. 
The data support the substrate-site hypothesis as the 
means whereby iV-acetylglucosamine is recognised as 
a signal by the beta-cell. 
2. Materials and methods 
2.1. Reagents 
Bovine albumin (fraction V), dibutyrylcyclic-3’S’- 
AMP and collagenase (Type 1) were obtained from 
Sigma Chemical Co. [ 12’1] Insulin and N-acetyl-D- 
[ l-r4C!] glucosamine were from the Radiochemical 
Centre, Amersham. Guinea pig anti-porcine insulin 
serum was obtained from Wellcome Reagents Ltd, 
phloretin was from K&K Labs. All other chemicals 
were from BDH and were of the highest purity 
available. 
2.2. Preparation of islets 
Islets were prepared using collagenase digestion 
[7] from pancreases of 200-300 g male albino Wistar 
rats fed ad libitum on a standard laboratory diet. 
2.3. Output of r4C02 
The rate of formation of 14C02 from N-acetyl-D- 
[ l-‘4C]glucosamine by islets was measured as in [8] . 
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2.4. Insulin release 
Batches of islets were incubated in vitro for 2 h 
and insulin release measured as in [2,6] . Radio- 
immunoassay of insulin was performed as in [S] , 
with the exception that Wellcome guinea pig anti- 
insulin serum was used as antibody. 
2.5. (Pro)insulin biosynthesis 
Rates of incorporation of L-[4,C3 Hlleucine into 
(pro)insulin and total islet protein were measured as 
in [6] . The rates of (pro)insulin biosynthesis are 
given as the insulin index: this parameter is the rate 
of (pro)insulin to total islet protein synthesis expressed 
as a fraction of the value of this ratio in the presence 
of 20 mM glucose in the same experiment. The term 
‘(pro)insulin’ is used to denote both insulin and pro- 
insulin since the insulin-binding columns used have 
affinity for proinsulin as well as insulin [6] . 
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Fig. 1. Dose-response curves for (a) N-acetylglucosamine oxidation, (b) Nacetylglucosamme-stimulated insulin release, (c) N-acetyl- 
glucosamine-potentiated insulin release and (d) N-acetylglucosamine-stimulated insulin biosynthesis. Oxidation, insulin release and 
insulin biosynthesis were measured as described in the text. Each point is the mean + SEM of the number of observations (n) 
shown above the point in the diagram. Abscissa: [N-acetylglucosamine] (mM): 0; 10; 20; 30; 40. Ordinate: (a) Oxidation (pmol 
“CO /lO islets/h): 0; 70; 140. (b) Insulin release (r.&J/islet/h): 0; 100; 200. (c) Insulin release @U/islet/h): 0; 70; 140. (d) Insulin 
index: 0; 0.6; 1.2. 
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3. Results 
3.1. N-Acetylglucosamine concentration and rates of 
oxidation, insulin release and biosynthesis 
The oxidation of N-acetyl-D-E l-‘4C]glucosamine 
to 14C02 was measured over a range of concentrations 
(fig. 1 a). A double reciprocal plot of velocity against 
N-acetylglucosamine concentration was linear over 
the range of concentrations tested. From the inter- 
cepts of this plot, a Km value for N-acetylglucosamine 
of 25.9 mM and a V,, value of 214 pmol/h/lO islets 
were determined. 
Two dose-response curves for the effects of 
N-acetylglucosamine on insulin release were measured: 
1. A curve for N-acetyl-glucosamine-potentiated 
release obtained by varying the concentration of 
N-acetylglucosamine  the presence of a sub- 
stimulatory (3.3 mM) concentration of glucose 
(f&lb). 
2. A curve for N-acetyl-glucosamine-stimulated insulin 
release obtained in the absence of glucose (fig.lc). 
The curves were sigmoidal and half-maximal rates of 
insulin release were observed at concentrations of
N-acetylglucosamine similar to the Km for N-acetyl- 
glucosamine oxidation. 
The concentration dependence ofN-acetylglucos- 
amine-stimulated (pro)insulin biosynthesis shown 
in fig.ld. The curve was similar to that found for 
insulin release. Thus the Km for N-acetylglucosamine 
oxidation, -potentiated insulin release, -stimulated 
insulin release and -stimulated (pro)insulin bio- 
synthesis are similar. When each of these parameters 
was expressed as a percentage of its value at 20 mM 
N-acetylglucosamine and plotted against N-acetyl- 
glucosamine concentration, a striking similarity 
between the concentration dependence of the four 
processes was observed (fig.2). 
3.2. Effects of caffeine, 34sobutylmethylxanthine 
and dibutyrylcyclic-3’5’iAMP on N-acetyl- 
glucosamine oxidation and Nacetylglucosamine- 
stimulated insulin release 
The results are shown in tables 1 and 2. Caffeine 
(5 mM) inhibited N-acetylglucosamine-stimulated 
insulin release and N-acetylglucosamine oxidation by 
CN-rcatylglucortminel mmol 1-t 
Fig.2. Normalised dose-response curves for N-acetylglutos- 
amine oxidation (o), N-acetylglucosamine-stimulated insulin 
release (A), N-acetyi@ucosaminepotentiated insulin release 
(A) and Kacetylglucosamine-stimulated insulin biosyn- 
thesis (0). Parameters were measured as described in legend 
to tig. 1. Points are mean of number of observations (n) shown 
in the corresponding fig.1. Rates of the various processes are 
normal&d by expressing them as a percentage of rate with 
20 mM N-acetylglucosamine (low?). Abscissa: [N-acetyl- 
glucosamine] (mM): 0; 10; 20; 30; 40. Ordinate: Rate (% rate 
with 20 mM N-acetylglucosamine). 
approx. 50%. Dibutyrylcyclic-3’5’-AMP (1mM) did 
not affect N-acetylglucosamine oxidation but increased 
the rate of N-acetylglucosamine-stimulated insulin 
release. 3-Isobutylmethylxanthine (0.5 mM) inhibited 
the oxidation of N-acetylglucosamine to a similar 
extent to that found with caffeine. 
3.3. Effects of phloretin on islet responses to 
N-acetylglucosamine 
A concentration of phloretin without detectable 
effect on islet responses to glucose [9] produced 
marked inhibition of N-acetyl- [1 -14C] glucosamine 
and N-acetylglucosamine-stimulated insulin release 
(tables 3,4). Similar concentrations of phloretin 
specifically reduced (pro)insulin biosynthesis: insulin 
index 0.75 1 + 0.044 (n = 12) with 20 mM N-acetyl- 
glucosamine, 0.238 + 0.051 (n = 6) with 2 pg/ml 
phloretin plus 20 mM N-acetylglucosamine. 
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Table 1 
Effects of caffeine and dibutyrylcyclic-3’5’-AMP on N-acktylglucosamine-stimulated insulin release 
Line Additions to the medium Insulin release rU/h/islet 
(mean f SEM) 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
None 21.4 f 2.1 
Caffeine 5 mM 30.5 + 7.3 
Glucose 10 mM 163.7 + 13.2 
Glucose 10 mM + 301.1 + 17.7 
caffeine 5 mM 
N-Acetylglucosamine 20 mM 87.4 + 3.4 
N-Acetylglucosamine 20 mM + 44.2? 3.5 
caffeine 5 mM 
iV-Acetylglucosamine 20 mM + 165.2 f 6.6 
dibutyrylcyclic3’5’-AMP 1 mM 
No. Significance 
45 
15 
15 
15 
45 
45 
10 
- 
NSvsl 
P G 0.001 vs 1 
P d 0.001 vs 3 
P G 0.001 vs 1 
P < 0.001 vs 5 
NS vs 2 
P =G 0.001 vs 5 
Batches of 5 islets were incubated for 2 h at 37°C in Krebs-Henseleit bicarbonate medium containing 2 mg/ml 
albumin plus the additions shown in the table. Insulin released into the medium was determined by radio- 
immunoassay. The statistical significance of differences was assessed using Student’s i-test 
Table 2 
Effects of caffeine, 3Gsobutylmethylxanthine and dibutyryl-CAMP onN-[ Y]acetylglucosamine oxidation 
Line Additions to the medium Oxidation pmol CO,/10 islets/h No. 
(mean k SEM) obs. 
Significance 
1. N-Acetylglucosamine 10 mM 74.3 k 4.9 24 _ 
2. N-Acetylglucosamine 10 mM + 
Caffeine 5 mM 38.3 f 3.4 16 P < 0.001 vs 1 
3. N-Acetylglucosamine 20 mM 210.8 t. 26.5 8 - 
4. N-Acetylglucosamine 20 mM + 
caffeine 5 mM 88.2 f 6.0 8 P d 0.001 vs 3 
5. N-Acetylglucosamine 10 mM + 
isobutylmethylxanthine 0.5 mM 34.1 + 1.6 8 P < 0.001 vs 1 
6. N-Acetylglucosamine 10 mM + 
dibutyryl-cAMP 1 mM 66.8 f 7.4 8 NS vs 1 
Batches of 10 islets were incubated for 2 h withN-acetyl-D-[ 1-“C]glucosamine (1 mCi/mmol). Metabolism was 
arrested by the addition of 0.2 N HCl and “CO, absorbed by hyamine and counted using liquid scintillation 
spectrometry. The statistical significance of differences was assessed using Student’s t-test 
Table 3 
Effect of phloretin on the oxidation of&[ “C]acetylglucosamine 
Line N-Acetylglucosamine Phloretin Oxidation pmol CO,/10 islets/h No. 
(mM) (pg/ml) (mean + SEM) obs. 
Significance 
1. 10 - 85.1 r 9.2 8 - 
2. 10 1.6 47.0 f 9.8 8 P < 0.05 vs 1 
3. 10 2.4 30.1 f 4.8 8 P < 0.001 vs 1 
4. 10 4.0 24.4 f 3.4 8 Pi 0.001 vs 1 
The experimental and statistical methods were as described in table 2. All of the above incubations contained 0.017% 
ethanol 
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Table 4 
Effects of phloretin on N-acetylglucosamine-stimulated insulin release 
Line Additions to the medium 
Stimulant Phloretin @g/ml) 
Insulin release pIJ/islet/h No. 
(mean f SEM) obs. 
Significance 
1. 
2. 
3. 
4. 
5. 
- 
20 mM glucose 
20 mM glucose 
20 mM N-acetylglucosamine 
20 mM N-acetylglucosamine 
- 
_ 
5 
- 
5 
29.3 r 7.2 15 - 
237.7 + 12.0 10 P 4 0.001 vs 1 
316.4 * 17.0 10 _ 
63.8 f 5.3 15 P G 0.001 vs 1 
24.5 + 3.0 15 P < 0.001 vs 4 
The experimental and statistical methods were as described in Table 1. AlI of the above media contained 0.017% ethanol 
4. Discussion 
It has been shown that N-acetylglucosamine is 
oxidised by pancreatic islets [2] which possess a 
specific N-acetylglucosamine kinase [lo] , and is able 
to stimulate insulin release [2,5,6] and biosynthesis 
[6]. The present study has examined in more detail 
the correlation between the metabolism of N-acetyl- 
glucosamine and its effects on islet function. 
The maximum rate of oxidation of N-acetyl- 
glucosamine was 214 pmol/h/lO islets. This is con- 
siderably less than the total amount of N-acetyl- 
glucosamine kinase in rat islets (2 nmol/h/lO islets); 
moreover the Km forN-acetylglucosamine ofN-acetyl- 
glucosamine kinase is 30 I.IM [lo] which is very much 
lower than the Km for N-acetylglucosamine oxidation. 
These data suggest hat, in contrast to glucose, the 
rate-limiting step of N-acetylglucosamine utilization 
may be membrane transport. The great sensitivity 
of N-acetylghrcosamine oxidation to phloretin, which 
contrasts with glucose oxidation, supports this view. 
The concentration of N-acetylglucosamine that 
gave half-maximum rates of oxidation was similar to 
that at which half-maximum rates of insulin release 
(in the presence or absence of 3.3 mM glucose) and 
biosynthesis occurred. These data are consistent with 
the hypothesis that N-acetylglucosamine metabolism 
may underlie its recognition by the beta-cell as a 
signal for insulin release and biosynthesis. 
This conclusion is strengthened by the results 
obtained with caffeine and phloretin. PhIoretin has 
been shown to inhibit the transport of glucose into 
isolated islets and to inhibit glucose-stimulated insulin 
release [9,1 l] . Glucose utilization by the islet is 
relatively insensitive to phloretin, however, as the 
transport capacity is greatly in excess of the phos- 
phorylating activity [9]. The converse appears to be 
true for N-acetylglucosamine metabolism. Concentra- 
tions of phloretin without detectable effect on islet 
responses to glucose markedly inhibit N-acetylglucos- 
amine oxidation and, in parallel, the biosynthetic and 
secretory responses to N-acetylglucosamine are also 
inhibited. 
Earlier studies [2,6,10] had indicated thathr-acetyl- 
glucosamine was not a stimulator of insulin release 
unless a low concentration of glucose was also present 
although insulin biosynthesis was stimulated by 
N-acetylglucosamine in the absence of glucose. How- 
ever in the earlier studies, 5 mM caffeine was included 
in the incubation media with the aim of maximizing 
the sensitivity of insulin release to various sugars 
tested. The finding of the present study that N-acetyl- 
glucosamine alone is able to stimulate insulin release 
(in the absence of caffeine) removes this apparent 
dichotomy between the biosynthetic and release 
responses and further supports the view that the two 
processes are stimulated in the same way. A low 
glucose concentration is required however for effects 
of fructose on release and biosynthesis of insulin 
(I.H.W. unpublished observations). Our studies on the 
interaction of caffeine with N-acetylglucosamine 
show that caffeine inhibits N-acetylglucosamine- 
stimulated insulin release: since insulin release rates 
in control incubations without added sugar were 
marginally higher in the presence of caffeine, the net 
effect is that in the presence of caffeine N-acetyl- 
glucosamine elicits no significant stimulation of 
insulin release. Although surprising in view of its 
marked potentiatory action on stimulation of insulin 
release by other sugars, this inhibitory effect of 
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caffeine permits further strengthening of the substrate- 
site model for N-acetylglucosamine-stimulated 
insulin release; we find that caffeine inhibits N-acetyl- 
glucosamine oxidation by islets and suggest that this 
inhibition of metabolism underlies its impairment of 
N-acetylghrcosamine-stimulated insulin release. 
The way in which caffeine (or 34sobutylmethyL 
xanthine) inhibits N-acetylglucosamine oxidation and 
N-acetylglucosamine-stimulated insulin release is not 
completely known. The possibility that the effect is 
mediated by cyclic-3’S’-AMP is unlikely since the 
effects of caffeine were not reproduced by dibutyryl 
cyclic-3’S’-AMP. A direct effect of caffeine on 
N-acetylglucosamine kinase also seems unlikely since, 
as we have argued above, the kinase is not rate- 
limiting for N-acetylglucosamine utilization, and, in 
preliminary studies on purified rat liver N-acetyl- 
glucosamine kinase, we find no effect of caffeine. 
Thus the only potential sites of action of caffeine are 
either at the level of N-acetylglucosamine transport 
into the cell or at some point in the metabolism of 
N-acetylglucosamine after the formation of N-acetyl- 
glucosamine-6-phosphate and before the entry into 
glycolysis. Further studies on the pathway by which 
N-acetylglucosamine s metabolised by islets are 
required to resolve this point. 
We conclude from these studies that there exists 
a close correlation between the metabolism of 
N-acetylglucosamine and its ability to stimulate insulin 
release and biosynthesis; and suggest that the 
substrate-site hypothesis may apply to this sugar. 
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